Dr. Andrews relocated her lab to the University of Florida College of Medicine Department of Pathology, Immunology & Laboratory Medicine.
An engineered AAV capsid mediates efficient transduction of pericytes and smooth muscle cells of the brain vasculature
New Manuscript Under Review
The use of tissue engineering to fabricate perfusable 3D brain microvessels in vitro
Kalpani Udeni Galpayage Dona, Jonathan Franklin Hale, Tobi Salako, Kiet A Tran, Brandon J DeOre, Peter Adam Galie, Servio Heybert Ramirez and Allison Michelle Andrews
Drexel Magazine's Top 40 Under 40 Nominee Dr. Allison Andrews
https://drexelmagazine.org/2021/allison-andrews/
Allison M. Andrews’ interest in understanding human physiology has propelled her to investigate ways to simulate tissue environments on a chip. From her days as a graduate student at Drexel, she became fascinated with the biomechanics of fluid flow within the vasculature and the commonality that the vascular system has with so many ubiquitous health ailments such as high blood pressure, diabetes, strokes and cancer. Her unique perspective as a biomedical engineer has resulted in two patents, funding from the National Institutes of Health (NIH), numerous publications in high-impact journals and other accolades. As an assistant professor at the Lewis Katz School of Medicine at Temple University, she has developed a premier program that focuses on the use of microfluidics, tissue engineering, and 3D printing to recreate the neurovascular unit (NVU) on a chip. “These powerful tools have endless applications, but I’m most excited about the exquisite details such devices can provide for studying neuroinflammation, such as that seen in HIV infection, sepsis, neurotrauma or multiple sclerosis,” she says. Her work hasn’t been lost on the NIH; in 2019, Andrews received the highly competitive and coveted NIH Mentored Research Scientist Development Award to explore immune-endothelial interactions. Notably, she has expanded her purview to include the study of cellular events associated with SARS-CoV-2 in order to better understand the neurological deficits seen in COVID-19 patients. Her co-authored studies on SARS-CoV-2 in the December issue of the Neurobiology of Disease is currently one of the top-read and top–cited papers in the journal.
New Laboratory Assistant!!
We want to welcome Whitney Blodgett, B.S. to the Andrews Laboratory Team!
New Graduate Research Assistant
We want to welcome Saaurav Bari, B.S. to the Andrews Laboratory Team!
New Manuscript Under Review
Title: A Qualitative Study of Substance Use and Intimate Partner Violence Among Young Gay and Bisexual Men
Authors: Jonathan F Hale, Christopher B. Stults, Nicolas Horne, Shaina Pomerantz, Stephan A. Brandt, Charles W. Cange, and Allison M Andrews
New Publication
The SARS-CoV-2 spike protein alters barrier function in 2D static and 3D microfluidic in-vitro models of the human blood-brain barrier.
Authors: Tetyana P Buzhdygan, PhD; Brandon J DeOre, BS; Abigail Baldwin-Leclair, BS; Trent A Bullock, BS, MA; Hannah McGary, BS; Jana A Khan, BS; Roshanak Razmpour, BS; Jonathan F Hale, BS, MA; Peter A Galie, PhD; Raghava Potula, PhD; Allison M Andrews, PhD; Servio H Ramirez, PhD
Welcome Our Newest Team Member
We want to welcome Akanksha to the Andrews Lab Team! Welcome!
Shellynea Reynolds Awarded Master's of Public Heath Degree!
We are very proud of our team member, Shellynea Reynolds, for receiving her Master’s of Public Health degree.
New Paper Under Review
The psychoactive drug of abuse mephedrone differentially disrupts blood-brain barrier properties.
New Paper Under Review
ErbB3 is a critical regulator of cytoskeletal dynamics in brain endothelial cells: implications for modulation of the blood brain barrier.
New Paper Under Review: Covid
The SARS-CoV-2 spike protein alters barrier function in an in-vitro model of the human blood-brain barrier.
New Lab Manager
We would like to welcome Jonathan Hale to the Andrews Laboratory Team!